Zoloft (sertraline), Lexapro (escitalopram), Prozac (fluoxetine), and Celexa (citalopram) are the four best-known brand names among selective serotonin reuptake inhibitors, the most commonly prescribed class of antidepressant in the United States. Pfizer's Zoloft treats major depressive disorder, obsessive-compulsive disorder, panic disorder, PTSD, social anxiety disorder, and premenstrual dysphoric disorder. AbbVie's Lexapro, through the company's 2020 acquisition of Allergan, which had earlier acquired Forest Laboratories, is FDA-approved for major depressive disorder and generalized anxiety disorder. Eli Lilly's Prozac, the first SSRI approved in the US in 1987, treats major depressive disorder, OCD, bulimia nervosa, and panic disorder, and is also sold under the brand Sarafem for premenstrual dysphoric disorder. AbbVie's Celexa is FDA-approved for major depressive disorder only, and the FDA has warned against doses above 40 mg per day because of a dose-dependent QT-interval prolongation risk. All four drugs work by blocking the reuptake of serotonin in the brain, though they differ in half-life, drug interactions, and side-effect profile, which is why switching between them should always involve your prescriber rather than a pharmacy substitution alone.
Generic competition eliminated most of the cost difference between these four SSRIs years before Medicare gained the power to negotiate drug prices. Generic fluoxetine (Prozac) reached pharmacies in August 2001, generic citalopram (Celexa) followed in 2004, generic sertraline (Zoloft) in 2006, and generic escitalopram (Lexapro) in March 2012 after a pediatric-exclusivity extension delayed its patent expiration. The Inflation Reduction Act of 2022, signed August 16, 2022, authorized CMS to negotiate a Maximum Fair Price for the first 10 drugs selected in August 2023, but the statute excludes any drug that already faces generic competition. Because all four of these SSRIs had generics on the market well before that selection date, none of them was ever eligible for IRA negotiation and none will carry a Maximum Fair Price in 2026 or any future round. That is also why none of the four needed a Medicare-negotiated price to become affordable: retail generic competition already drove the cash price down to $2 to $20 per month years ago.
Patients switching among Zoloft, Lexapro, Prozac, and Celexa for cost reasons should still consult their prescriber, since all four generics are already inexpensive and switching SSRIs carries a real risk of withdrawal symptoms, a return of depression or anxiety symptoms, and drug-interaction differences, for example fluoxetine's long half-life and stronger CYP2D6 inhibition compared with escitalopram or sertraline. None of the four is a biologic, so the biosimilar approval pathway used for large-molecule drugs like Humira or Stelara does not apply to any of them; cost reduction for these small-molecule SSRIs comes entirely from generic competition rather than biosimilar competition. Patients who are uninsured and cannot afford even the generic price should compare their household income against their state's Medicaid income limits, since Medicaid covers all four SSRIs in every state with a $1 to $4 copay. The comparison table below breaks down brand and generic cash price, Medicare Part D tier, and FDA-approved indications for all four drugs side by side.
What SSRI Comparison Costs by Point of Pay (2026)
The price you pay depends almost entirely on WHERE you pay. The same ssri comparison can cost many times more at a hospital than at your local pharmacy:
2026 SSRI Comparison Price by Point of Pay| Where you pay | Typical cost | Notes |
|---|
| Pharmacy counter (retail, generic cash or coupon) | $2 - $20/month | Walmart's $4 Generic Prescription Program covers all four drugs; Costco, Kroger, CVS, and Walgreens run $7 - $20 with a free GoodRx or SingleCare coupon; see the pharmacy comparison table below for per-drug detail |
| Pharmacy counter (retail, brand-name cash) | $200 - $650/month | Rarely dispensed since all four have generics; Celexa brand is cheapest at $200 - $320, Prozac brand is priciest at $450 - $650 |
| Medicare Part D (2026) | $0 - $5/month generic Tier 1 copay | All four generics sit on Tier 1 at nearly every Part D plan; brand-name fills, when medically necessary, usually land on Tier 3 or higher with a $30 - $60 copay; falls under the 2026 $2,100 annual Part D out-of-pocket cap |
| Commercial insurance | $0 - $15/month generic copay | Prior authorization is uncommon for generic SSRIs; brand-only prescriptions may trigger a formulary tier exception request |
| Medicaid | $1 - $4/prescription | Covered as a preferred generic in all 50 states; brand-name fills typically require prior authorization or a documented generic-allergy exception |
Retail prices reflect 2026 GoodRx, SingleCare, and Walmart Prescription Program data. Medicare Part D tier placement and copay amounts vary slightly by plan; confirm your specific plan's formulary before filling.
Source: GoodRx 2026, SingleCare 2026, Walmart $4 Prescription Program, CMS Medicare Part D 2026 Benefit Parameters
Why Hospitals Charge So Much
Hospitals rarely bill Zoloft, Lexapro, Prozac, or Celexa as a standalone pharmacy line item when a patient continues a home SSRI prescription during an inpatient psychiatric or medical stay. Instead, the daily tablet is typically bundled into the hospital's per-diem or Diagnosis-Related Group (DRG) payment, the same reimbursement structure that covers nursing care, meals, and facility overhead for that admission. When an itemized bill does break out the SSRI as a separate charge, hospitals bill oral medications at facility rates that can run $30 to $120 per tablet, a markup of 10 to 40 times the $2 to $12 generic cash price at a retail pharmacy.
Uninsured or high-deductible patients who see an inflated SSRI charge on a hospital bill should request the full itemized statement and compare each drug line against the retail generic price. A seven-day inpatient stay with one tablet of generic sertraline per day, at $75 per tablet, can produce a $525 line item for a drug that costs $4 to $18 per month at Walmart or Costco. That kind of markup is a standard target for a bill dispute or a request for a self-pay discount, and the medical bill analyzer can flag line items priced far above the retail benchmark automatically.
None of these four SSRIs carries a Medicare Part B Average Sales Price rate because each is an oral drug self-administered at home and billed through Medicare Part D, not Part B. That means there is no HCPCS J-code for sertraline, escitalopram, fluoxetine, or citalopram, and hospitals have no single federal benchmark price to reference for inpatient oral-antidepressant charges. Comparing any hospital-billed SSRI line against the $2 to $20 retail generic price, or against the $0 to $5 Medicare Part D Tier 1 copay, remains the most reliable way to spot and dispute an inflated charge.
Patient Assistance Programs
Because generic sertraline, escitalopram, fluoxetine, and citalopram already cost $2 to $20 per month at major pharmacies, a formal manufacturer patient assistance program is rarely necessary. The programs below exist mainly for the small number of patients who must take a brand-name SSRI, typically due to a documented allergy or adverse reaction to an inactive ingredient in a specific generic formulation, and cannot afford the brand cash price.
Patient assistance programs for SSRI Comparison| Manufacturer program | Cost / Benefit | How to apply |
|---|
| AbbVie Patient Assistance Foundation (myAbbVie Assist) - Lexapro & Celexa | Free brand Lexapro or Celexa for qualifying uninsured or underinsured patients who cannot use an available generic; eligibility and income threshold determined case by case | abbvieaccess.com/patient-assistance |
| Lilly Cares Foundation - Prozac | Free brand Prozac for up to 12 months for uninsured patients or Medicare Part D enrollees who meet income requirements; annual reapplication required | lillycares.com |
| Pfizer RxPathways - Zoloft | Free or reduced-cost brand Zoloft plus insurance counseling for eligible uninsured and underinsured patients | pfizerrxpathways.com |
| NeedyMeds Drug Discount Card | Variable discount on any of the four SSRIs, brand or generic, accepted at most US pharmacies, no income limit | needymeds.org |
Manufacturer savings coupons for brand Zoloft, Lexapro, Prozac, or Celexa are not available to Medicare, Medicaid, TRICARE, or VA beneficiaries by federal law (anti-kickback statute, 42 U.S.C. Section 1320a-7b). Because the generic versions of all four drugs already cost $2 to $20 per month, most Medicare and Medicaid patients never need to apply for the manufacturer's income-based patient assistance program instead of a manufacturer coupon.
Source: abbvieaccess.com, lillycares.com, pfizerrxpathways.com, needymeds.org
Medicare Part D
Medicare Part D places generic sertraline, escitalopram, fluoxetine, and citalopram on Tier 1 (preferred generic) at nearly every plan nationwide, with a typical copay of $0 to $5 per 30-day fill. There is no drug-specific federal monthly cap for any of the four SSRIs the way there is for insulin ($35 per month under the Inflation Reduction Act of 2022). All out-of-pocket spending on these SSRIs, along with every other Part D drug you take, counts toward the general 2026 annual out-of-pocket cap of $2,100; once you reach that cap, you pay $0 for covered drugs for the rest of the calendar year, though reaching $2,100 from these four generics alone is unlikely given how inexpensive they are.
Extra Help, the Part D Low-Income Subsidy, further reduces cost-sharing for Medicare beneficiaries with limited income and resources. In 2026, standard Extra Help enrollees pay no more than $5.10 per fill for a generic SSRI and $12.65 for a brand-name fill, while full-benefit dual-eligible beneficiaries, those who also have Medicaid, pay as little as $1.60 for a generic and $4.90 for a brand. Apply for Extra Help through the Social Security Administration at 1-800-772-1213 or at ssa.gov; approval typically also triggers automatic enrollment in a $0-premium Part D plan.
Common SSRI Comparison Billing Errors
If you received a bill for Zoloft, Lexapro, Prozac, or Celexa above $20 with commercial insurance, or above $5 on Medicare Part D Tier 1, check for these issues before paying:
- Brand-name drug billed when the generic was actually dispensed, a substitution error that can add hundreds of dollars to a single fill
- Generic SSRI placed on a higher formulary tier than Tier 1 by your Part D plan without a documented reason
- Inpatient hospital charge for a single SSRI tablet marked up to $30 to $120 when the retail generic price is $2 to $20 per month
- Wrong drug billed under the wrong NDC, for example citalopram's code appearing on a claim when escitalopram was actually dispensed, since the two names are easy to confuse at the pharmacy counter
- Charged a standard copay after you already hit the $2,100 Part D annual out-of-pocket cap for the year
- 90-day generic fill billed as three separate 30-day copays instead of the lower 90-day mail-order or retail rate most plans offer
Frequently Asked Questions
Is there a generic for Zoloft, Lexapro, Prozac, and Celexa?
Yes, all four. Generic fluoxetine (Prozac) has been available since August 2001, generic citalopram (Celexa) since 2004, generic sertraline (Zoloft) since 2006, and generic escitalopram (Lexapro) since March 2012. Each generic is FDA-approved bioequivalent to its brand and typically costs 90 percent or more below the brand cash price. Ask your pharmacist to fill the generic; no prescription change is usually needed since the brand and generic are interchangeable at most pharmacies.
Do I need a patient assistance program for these SSRIs?
Usually not. Generic sertraline, escitalopram, fluoxetine, and citalopram already cost $2 to $20 per month at major pharmacies, cheaper than most manufacturer patient assistance programs would offer. PAPs like myAbbVie Assist (Lexapro, Celexa), Lilly Cares (Prozac), and Pfizer RxPathways (Zoloft) exist mainly for patients who must use the brand due to a documented allergy or adverse reaction to a generic formulation's inactive ingredients.
Can I use a manufacturer coupon for Zoloft, Lexapro, Prozac, or Celexa with Medicare?
No. Federal anti-kickback law (42 U.S.C. Section 1320a-7b) bars Medicare, Medicaid, TRICARE, and VA beneficiaries from using manufacturer copay coupons on any drug. This rarely matters for these four SSRIs anyway, since the Medicare Part D Tier 1 generic copay ($0 to $5 in 2026) is already lower than most commercial coupon prices. If you need the brand and have Medicare, apply for the manufacturer's income-based patient assistance program instead of a manufacturer coupon.
What if my insurance denies coverage for my SSRI or requires a formulary exception?
Request a written denial notice, then file a formal appeal within 60 days with a letter from your prescriber documenting medical necessity. If your plan requires step therapy with a different antidepressant first, your prescriber can file a step-therapy override documenting a prior failed trial, adverse reaction, or contraindication. Because generic versions of all four SSRIs are inexpensive, most denials involve brand-name requests or a switch to a non-preferred formulation rather than the drug class itself.
Does the IRA Medicare negotiated price apply to Zoloft, Lexapro, Prozac, or Celexa?
No. None of the four carries a Maximum Fair Price under the Inflation Reduction Act of 2022. CMS can only select drugs without existing generic competition for negotiation, and generic sertraline, escitalopram, fluoxetine, and citalopram were all on the market years before CMS finalized its first Round 1 selection list in August 2023. Their low 2026 cost comes entirely from generic competition, not IRA negotiation.
What does each SSRI cost without insurance at the pharmacy counter in 2026?
Generic prices without insurance run $2 to $20 for a 30-day supply: about $4 to $18 for sertraline (Zoloft), $4 to $15 for escitalopram (Lexapro), $3 to $14 for fluoxetine (Prozac), and $2 to $12 for citalopram (Celexa), with Walmart's $4 Generic Prescription Program the cheapest single option for all four. Brand-name versions, rarely dispensed, run $200 to $650 per month depending on the drug.
Which SSRI is cheapest: Zoloft, Lexapro, Prozac, or Celexa?
As generics, all four are similarly inexpensive, generally $2 to $20 per month, so the cost difference between them rarely drives the prescribing decision. Citalopram (Celexa) tends to sit at the lower end of the generic range and has the cheapest brand-name floor if a brand is ever needed. Fluoxetine (Prozac) brand-name pricing is the highest of the four, but its generic price is comparable to the others. Choose based on clinical fit with your prescriber, not price, since all four generics cost about the same.
What is the difference between Zoloft, Lexapro, Prozac, and Celexa?
All four are SSRIs that block serotonin reuptake, but they differ in FDA-approved uses and pharmacology. Zoloft (sertraline) covers depression, OCD, panic disorder, PTSD, social anxiety, and PMDD. Lexapro (escitalopram) is approved for depression and generalized anxiety disorder. Prozac (fluoxetine), the first SSRI approved in the US in 1987, treats depression, OCD, bulimia nervosa, and panic disorder, and has the longest half-life of the four. Celexa (citalopram) is approved for depression only, with an FDA warning against doses above 40 mg per day due to a QT-prolongation risk.
